MD-THORACIC

MD-THORACIC is an injectable class III medical device:
- Treatment can be combined with other therapies.
- It improves the movement of the thoracic spine segment and reduces the associated pain.
- Counteracts physiological or pathological deterioration of the joints and tissues involved
- It can be combined with other treatments.

- GUNA S.P.A.
- NAME: MD-THORACIC
- COMPOSITION: Collagen of porcine origin, Cimicifuga racemosa, Sodium chloride, Water for injection.
- PRESENTATION: 10 x 2ml.
- INDICATIONS: Improves mobility of the thoracic spine and promotes relaxation of the thoracic muscles.
- INJECTION DEPTH:
Peri-articular: 26G x 13 mm needle; intra-muscular: 26G x 13 mm needle.
Note: Carry out thorough skin disinfection with iodopovidone or chlorhexidine.
Peri-articular route: introduce the needle close to the joint at a depth of 6-13 mm.
Intra-muscularly: introduce the needle into the trigger points at a depth of 5-8 mm.
- PROTOCOL: Peri-articular administration: 2 treatments for the first 2 weeks; then 1 treatment until symptomatology improves.
Results already evident from the third week but, depending on the patient's clinical situation, treatment can be continued up to the tenth week without risk.
For chronic conditions: continue with 1 treatment per week for a month until symptoms improve, and then 1 treatment per month thereafter.
- USE: Strict medical use.

- Vials: 10 x 2ml.

Thoracic section of the spine.

Collagen of porcine origin, Cimicifuga racemosa, Sodium chloride, Water for injection.

- The product should only be injected by trained operators, in a suitable environment, using aseptic technique.
- Injection test in patients with suspected hypersensitivity: if there is a history of allergic reactions, a preliminary intradermal/injective test and observation of the patient for at least 1 hour is recommended.
- Avoid immediate exercise/prolonged mobilisation of the treated area unless indicated.
- Do not extend treatment beyond 10 weeks unless clinically assessed; follow protocols indicated by the manufacturer.
- Do not use after the expiry date; use immediately after opening; do not use if the bottle is damaged.

MD-THORACIC is contraindicated in the following cases:
- Known hypersensitivity to components (e.g. collagen of porcine origin or other excipients).
- Septic processes or active local/articular infections: do not inject into infected areas or in the presence of an ongoing joint infection.

Counteracts physiological or pathological deterioration of joints and tissues involved in:
- Dorsal spinal ligament syndrome
- Postural disorders
- Dorsalgia:
- of muscular and/or nervous origin
- from ageing phenomena
- from postural defects
- by concomitant chronic diseases
- from trauma and injuries.